Cortistatin as a Novel Multimodal Therapy for the Treatment of Parkinson’s Disease

Cortistatin as a Novel Multimodal Therapy for the Treatment of Parkinson’s Disease

Parkinson’s disease (PD) is a complex disorder characterized by the impairment of the dopaminergic nigrostriatal system. PD has duplicated its global burden in the last few years, becoming the leading neurological disability worldwide. Therefore, there is an urgent need to develop innovative approac...

Full description

Bibliographic Details
Main Authors: Ignacio Serrano-Martínez, Marta Pedreño, Julia Castillo-González, Viviane Ferraz-de-Paula, Pablo Vargas-Rodríguez, Irene Forte-Lago, Marta Caro, Jenny Campos-Salinas, Javier Villadiego, Pablo Peñalver, Juan Carlos Morales, Mario Delgado, Elena González-Rey
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:International Journal of Molecular Sciences
Subjects:
cortistatin
neurodegenerative diseases
neuroinflammation
Parkinson’s disease
gliosis
Online Access:https://www.mdpi.com/1422-0067/25/2/694

Internet

https://www.mdpi.com/1422-0067/25/2/694

Similar Items